Some Democratic and Republican lawmakers said the FDA should ignore the Texas ruling that looks to rescind the agency’s approval of an abortion pill, The Hill reported April 11.
Three former executives of healthcare technology startup Outcome Health were found guilty by a federal jury April 11 on 47 charges of fraud and acquitted of seven charges.
A man has filed a lawsuit alleging that an algorithm used to determine priority for organs is biased against Black people, The Washington Post reported April 10.
A class-action lawsuit that alleges Florida’s Medicaid program has denied coverage for incontinence supplies for adults with disabilities is moving forward, radio station WMNF reported April 10.
Evanston, Ill.-based NorthShore University HealthSystem and one of its former obstetrician-gynecologists will pay $35 million to settle a lawsuit alleging the physician was negligent when delivering a baby, The Chicago Tribune reported April 10.
Three days before a federal judge’s preliminary injunction takes effect to block the abortion pill mifepristone, hundreds of biotech and pharma leaders have condemned the ruling, and some states are stocking up.
A federal appeals court rejected former Theranos COO Ramesh “Sunny” Balwani’s request to delay prison time until a decision on his appeal is made, NBC affiliate KNTV reported April 7.
In an unprecedented decision, a federal judge in Texas ruled April 7 to suspend the FDA’s decadeslong approval of one of the two abortion pills, effective April 14.